# CENTESSA PHARMACEUTICALS PLC (CNTA)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CNTA/

- Reporting holders: 1
- Reported value: $231
- Held through calls: 0.0%
- Held through puts: 100.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [SIMPLEX TRADING, LLC](https://holderbook.com/funds/1488542-simplex-trading-llc/) | $231 | 0 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 1 | $231 |
| Q1 2026 | 164 | $6.0B |
| Q4 2025 | 148 | $3.6B |
| Q3 2025 | 129 | $3.2B |
| Q2 2025 | 123 | $1.6B |
| Q1 2025 | 134 | $1.8B |
| Q4 2024 | 114 | $2.1B |
| Q3 2024 | 104 | $1.7B |
| Q2 2024 | 81 | $785.5M |
| Q1 2024 | 70 | $889.6M |
| Q4 2023 | 60 | $577.3M |
| Q3 2023 | 49 | $469.8M |